SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs&Pharma - Quaterly Results

08 Oct 2022 Evaluate
The revenue slipped marginally during the September 2022 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2022 is Rs. -0.07 millions as compared to Net Loss of Rs. -0.14 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -0.07% as compared to -0.14% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.22 0.00 1.05 1.33 -21.05
Other Income 0.09 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.00
PBIDT -0.07 -0.14 -50.00 -0.64 -0.38 68.42 0.24 0.55 -56.36
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.07 -0.14 -50.00 -0.64 -0.38 68.42 0.24 0.55 -56.36
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.07 -0.14 -50.00 -0.64 -0.38 68.42 0.24 0.55 -56.36
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.07 -0.14 -50.00 -0.64 -0.38 68.42 0.24 0.55 -56.36
Equity 134.39 121.19 10.89 134.39 121.19 10.89 121.19 121.19 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 -172.73 0.00 22.86 41.35 -44.73

Welcure Drugs&Pharma Share Price

0.31 -0.01 (-3.13%)
20-Apr-2026 14:37 View Price Chart
Peers
Company Name CMP
Redington 227.90
Adani Enterprises 2247.70
Amrapali Industries 17.99
Rashi Peripheral 474.20
PDS 293.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×